Japanese Catheter Ablation Registry

Recruiting

• Conditions: Cardiac Arrhythmias; Catheter Ablation

• Registration Number: NCT03729232
• Lead Sponsor: National Cerebral and Cardiovascular Center, Japan

Brief Summary

Japanese Cather Ablation (J-AB) Registry is a voluntary nationwide registry, performed by Japanese Heart Rhythm Society, collaborated with the National Cerebral and Cardiovascular Center. The objectives of this registry are to observe and describe developments in the catheter ablation treatment of arrhythmia in Japan and to provide reliable information on the type of activity performed and the facilities available in Japanese arrhythmia units.

Detailed Description

Japanese Cather Ablation (J-AB) Registry is a nationwide, multicenter, observational registry, performed by Japanese Heart Rhythm Society, collaborated with National Cerebral and Cardiovascular Center.

This study is a voluntary nationwide registry and data are collected prospectively using a Research Electronic Data Capture (REDCap) system. Detailed data collection including antiarrhythmic medication is also performed at every September. The acute success rate at discharge and the complications associated with ablation procedure will be collected in all cases. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria. Based on the provided information, the annual incidence and predictive factors for outcome will be investigated by the event assessment committee.

Study Timeline

• Study Start: 2017-07-01
• Study First Submitted: 2018-10-31
• Study First Submitted QC: 2018-11-01
• Study First Posted: 2018-11-02
• Status Verified: 2023-11
• Last Update Submitted: 2023-11-09
• Last Update Posted: 2023-11-13
• Primary Completion: 2030-03-31
• Study Completion: 2030-03-31

Recruitment & Eligibility

• Status: RECRUITING
• Sex: All
• Target Recruitment: 400000

Inclusion Criteria

• Patients treated with catheter ablation in Japan

Exclusion Criteria

• Patients who refused to consent

Study & Design

• Study Type: OBSERVATIONAL
• Study Design: Not specified

Primary Outcome Measures

Name	Time	Method
Number of patients with recurrence of targeted arrhythmia	Through discharge from hospital, approximately up to 1 weeks

Secondary Outcome Measures

Name	Time	Method
Number of patients with treatment-related complications	3 months	Bleeding events, embolic events, other all complications. Major bleeding events are defined according to Bleeding Academic Research Consortium criteria.
Number of deaths	Through discharge from hospital, approximately up to 1 weeks	All-cause death, cardiovascular death, and procedure-related death

Trial Locations

Locations (1)

National Cerebral and Cardiovascular Center; 🇯🇵 Suita, Osaka, Japan